Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing immunogenicity and safety of a meningococcal ACYW135 polysaccharide conjugate vaccine in infants aged 3 to 5 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Meningococcal ACYW135 polysaccharide conjugate vaccine (Meningococcal conjugate vaccine ACYW135)

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Meningitis, Meningococcal | Phase 3 | Status: UNKNOWN